Bimeda Inc
Pharmaceutical ManufacturingMinnesota, United States51-200 Employees
Bimeda Inc is a Pharmaceuticals company located in 291 Forest Prairie Rd, Le Sueur, Minnesota, United States.
Geographic Expansion Bimeda has strategically expanded its footprint through recent partnerships in the US and UK, and an acquisition in South Africa, indicating a growing presence in diverse markets which offers opportunities to introduce new products and services.
Leadership Growth The hiring of experienced regional managers and technical directors suggests an emphasis on strengthening local sales teams and technical support, providing opportunities to collaborate on targeted sales strategies and territorial growth.
Product Diversification Recent collaborations and acquisitions, including equine-specific product distribution and Afrivet’s animal health portfolio, highlight Bimeda’s focus on expanding its product range, creating opportunities for cross-selling and new product promotion.
Market Position With an estimated revenue range of 10 to 25 million dollars and a growing employee base, Bimeda is positioned as a midsize player in the pharmaceutical manufacturing industry, offering potential sales growth in niche segments within animal health.
Technological Tools Utilization of advanced software such as SAP and Hyperion indicates a focus on operational efficiency, creating opportunities to align sales efforts with streamlined processes and data-driven decision making.
Bimeda Inc uses 8 technology products and services including QuickBooks, WordPress, Hyperion, and more. Explore Bimeda Inc's tech stack below.
| Bimeda Inc Email Formats | Percentage |
| FLast@bimeda.com | 91% |
| First.Last@bimeda.com | 7% |
| FirstLast@bimeda.com | 1% |
| LastF@bimeda.com | 1% |
Pharmaceutical ManufacturingMinnesota, United States51-200 Employees
Bimeda Inc is a Pharmaceuticals company located in 291 Forest Prairie Rd, Le Sueur, Minnesota, United States.
Bimeda Inc's revenue is estimated to be in the range of $10M$25M
Bimeda Inc's revenue is estimated to be in the range of $10M$25M